---
document_datetime: 2025-12-29 11:44:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/abilify-maintena.html
document_name: abilify-maintena.html
version: success
processing_time: 0.1305826
conversion_datetime: 2025-12-29 23:25:27.7524
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Abilify Maintena

[RSS](/en/individual-human-medicine.xml/66624)

##### Authorised

This medicine is authorised for use in the European Union

aripiprazole Medicine Human Authorised

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Abilify Maintena](#news-on)
- [Product information - with tracked changes](#product-information-with-tracked-changes-80530)
- [Topics](#topics)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

Abilify Maintena is an antipsychotic medicine that contains the active substance aripiprazole. It is used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised with aripiprazole taken by mouth.

Schizophrenia is a mental illness with a number of symptoms, including disorganised thinking and speech, hallucinations (hearing or seeing things that are not there), suspiciousness and delusions (false beliefs).

Expand section

Collapse section

## How is Abilify Maintena used?

Abilify Maintena is available as a powder and solvent to be made into a prolonged-release suspension for injection. 'Prolonged release' means that the active substance is released slowly over a few weeks after being injected. The medicine is given once a month by slow injection into the buttock or deltoid (shoulder) muscle by a doctor or nurse. It must not be injected into a vein or under the skin.

The recommended dose depends on whether the patient is taking other medicines that slow the breakdown of aripiprazole in the body and may be reduced if the patient experiences side effects. Treatment beyond 2 weeks with medicines that speed up the breakdown of aripiprazole should be avoided. The first treatment consists of either one injection followed by aripiprazole taken by mouth daily for 2 weeks or two injections and a single dose of aripiprazole by mouth on the same day.

The medicine can only be obtained with a prescription.

## How does Abilify Maintena work?

The active substance in Abilify Maintena is aripiprazole. The exact way it works is not known but it attaches to receptors in the brain for two substances (neurotransmitters) called dopamine and serotonin, which are believed to play a role in schizophrenia. By attaching to these receptors, it is thought that aripiprazole helps normalise the activity of the brain, reducing psychotic symptoms and preventing them from returning.

## What benefits of Abilify Maintena have been shown in studies?

Abilify Maintena was shown to be as effective as aripiprazole taken by mouth at preventing symptoms of schizophrenia from returning. In one main study involving adults whose disease had already been stabilised with aripiprazole taken by mouth, 22 out of the 265 patients (8.3%) treated with Abilify Maintena had symptoms coming back within 26 weeks, compared with 21 out of 266 (7.9%) patients treated with aripiprazole taken by mouth.

## What are the risks associated with Abilify Maintena?

The most common side effects with Abilify Maintena (which may affect 5 or more people in 100) are increased weight, akathisia (a constant urge to move), insomnia (difficulty sleeping) and injection site pain. For the full list of all side effects reported with Abilify Maintena, see the package leaflet.

## Why is Abilify Maintena authorised in the EU?

Abilify Maintena is as effective as aripiprazole taken by mouth and has a similar safety profile with the exception of injection pain, which was considered manageable. The monthly administration may help patients adhere to their treatment. The European Medicines Agency therefore decided that Abilify Maintena's benefits are greater than its risks and it can be authorised for use in the EU.

## What measures are being taken to ensure the safe and effective use of Abilify Maintena?

Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Abilify Maintena have been included in the summary of product characteristics and the package leaflet.

As for all medicines, data on the use of Abilify Maintena are continuously monitored. Side effects reported with Abilify Maintena are carefully evaluated and any necessary action taken to protect patients.

## Other information about Abilify Maintena

Abilify Maintena received a marketing authorisation valid throughout the EU on 15 November 2013.

Abilify Maintena : EPAR - Summary for the public

Reference Number: EMA/556764/2020

English (EN) (129.85 KB - PDF)

**First published:** 28/11/2013

**Last updated:** 02/12/2020

[View](/en/documents/overview/abilify-maintena-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-729)

български (BG) (142.72 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/bg/documents/overview/abilify-maintena-epar-summary-public_bg.pdf)

español (ES) (118.48 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/es/documents/overview/abilify-maintena-epar-summary-public_es.pdf)

čeština (CS) (140.03 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/cs/documents/overview/abilify-maintena-epar-summary-public_cs.pdf)

dansk (DA) (118.2 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/da/documents/overview/abilify-maintena-epar-summary-public_da.pdf)

Deutsch (DE) (121.31 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/de/documents/overview/abilify-maintena-epar-summary-public_de.pdf)

eesti keel (ET) (107.76 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/et/documents/overview/abilify-maintena-epar-summary-public_et.pdf)

ελληνικά (EL) (141.51 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/el/documents/overview/abilify-maintena-epar-summary-public_el.pdf)

français (FR) (119.89 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/fr/documents/overview/abilify-maintena-epar-summary-public_fr.pdf)

hrvatski (HR) (138.86 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/hr/documents/overview/abilify-maintena-epar-summary-public_hr.pdf)

italiano (IT) (117.21 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/it/documents/overview/abilify-maintena-epar-summary-public_it.pdf)

latviešu valoda (LV) (150.36 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/lv/documents/overview/abilify-maintena-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (140.69 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/lt/documents/overview/abilify-maintena-epar-summary-public_lt.pdf)

magyar (HU) (137.87 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/hu/documents/overview/abilify-maintena-epar-summary-public_hu.pdf)

Malti (MT) (148.89 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/mt/documents/overview/abilify-maintena-epar-summary-public_mt.pdf)

Nederlands (NL) (118.68 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/nl/documents/overview/abilify-maintena-epar-summary-public_nl.pdf)

polski (PL) (142.77 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/pl/documents/overview/abilify-maintena-epar-summary-public_pl.pdf)

português (PT) (119.52 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/pt/documents/overview/abilify-maintena-epar-summary-public_pt.pdf)

română (RO) (138.23 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/ro/documents/overview/abilify-maintena-epar-summary-public_ro.pdf)

slovenčina (SK) (140.3 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/sk/documents/overview/abilify-maintena-epar-summary-public_sk.pdf)

slovenščina (SL) (136.29 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/sl/documents/overview/abilify-maintena-epar-summary-public_sl.pdf)

Suomi (FI) (116.76 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/fi/documents/overview/abilify-maintena-epar-summary-public_fi.pdf)

svenska (SV) (117.17 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

02/12/2020

[View](/sv/documents/overview/abilify-maintena-epar-summary-public_sv.pdf)

Abilify Maintena : EPAR - Risk management plan

English (EN) (4.36 MB - PDF)

**First published:** 14/09/2018

**Last updated:** 10/04/2024

[View](/en/documents/rmp/abilify-maintena-epar-risk-management-plan_en.pdf)

## Product information

Abilify Maintena : EPAR - Product Information

English (EN) (1.28 MB - PDF)

**First published:** 28/11/2013

**Last updated:** 28/10/2025

[View](/en/documents/product-information/abilify-maintena-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-315)

български (BG) (1.65 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

18/12/2025

[View](/bg/documents/product-information/abilify-maintena-epar-product-information_bg.pdf)

español (ES) (1.35 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/es/documents/product-information/abilify-maintena-epar-product-information_es.pdf)

čeština (CS) (2.44 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/cs/documents/product-information/abilify-maintena-epar-product-information_cs.pdf)

dansk (DA) (1.14 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/da/documents/product-information/abilify-maintena-epar-product-information_da.pdf)

Deutsch (DE) (1.33 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/de/documents/product-information/abilify-maintena-epar-product-information_de.pdf)

eesti keel (ET) (1.33 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/et/documents/product-information/abilify-maintena-epar-product-information_et.pdf)

ελληνικά (EL) (2.49 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/el/documents/product-information/abilify-maintena-epar-product-information_el.pdf)

français (FR) (1.36 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/fr/documents/product-information/abilify-maintena-epar-product-information_fr.pdf)

hrvatski (HR) (1.96 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/hr/documents/product-information/abilify-maintena-epar-product-information_hr.pdf)

íslenska (IS) (1.25 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/is/documents/product-information/abilify-maintena-epar-product-information_is.pdf)

italiano (IT) (1.34 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/it/documents/product-information/abilify-maintena-epar-product-information_it.pdf)

latviešu valoda (LV) (2.25 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/lv/documents/product-information/abilify-maintena-epar-product-information_lv.pdf)

lietuvių kalba (LT) (2.1 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/lt/documents/product-information/abilify-maintena-epar-product-information_lt.pdf)

magyar (HU) (1.88 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/hu/documents/product-information/abilify-maintena-epar-product-information_hu.pdf)

Malti (MT) (2.25 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/mt/documents/product-information/abilify-maintena-epar-product-information_mt.pdf)

Nederlands (NL) (1.32 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/nl/documents/product-information/abilify-maintena-epar-product-information_nl.pdf)

norsk (NO) (1009.72 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/no/documents/product-information/abilify-maintena-epar-product-information_no.pdf)

polski (PL) (2.35 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/pl/documents/product-information/abilify-maintena-epar-product-information_pl.pdf)

português (PT) (1.32 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/pt/documents/product-information/abilify-maintena-epar-product-information_pt.pdf)

română (RO) (2.3 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/ro/documents/product-information/abilify-maintena-epar-product-information_ro.pdf)

slovenčina (SK) (2.04 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/sk/documents/product-information/abilify-maintena-epar-product-information_sk.pdf)

slovenščina (SL) (1.91 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/sl/documents/product-information/abilify-maintena-epar-product-information_sl.pdf)

Suomi (FI) (1.28 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/fi/documents/product-information/abilify-maintena-epar-product-information_fi.pdf)

svenska (SV) (1.26 MB - PDF)

**First published:**

28/11/2013

**Last updated:**

28/10/2025

[View](/sv/documents/product-information/abilify-maintena-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0000308201 27/10/2025

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Abilify Maintena : EPAR - All Authorised presentations

English (EN) (41.17 KB - PDF)

**First published:** 28/11/2013

**Last updated:** 10/04/2024

[View](/en/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-2)

български (BG) (65.96 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/bg/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_bg.pdf)

español (ES) (34.02 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/es/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_es.pdf)

čeština (CS) (59.05 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/cs/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (31.8 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/da/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (31.32 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/de/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (34.89 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/et/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (62.8 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/el/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_el.pdf)

français (FR) (32.14 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/fr/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (54.19 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/hr/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (29.93 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/is/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_is.pdf)

italiano (IT) (32.29 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/it/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (58.42 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/lv/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (55.67 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/lt/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (56.06 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/hu/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (57.49 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/mt/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (31 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/nl/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (31.79 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/no/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_no.pdf)

polski (PL) (60 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/pl/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_pl.pdf)

português (PT) (31.46 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/pt/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_pt.pdf)

română (RO) (58.18 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/ro/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (60.59 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/sk/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (54.03 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/sl/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (30.77 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/fi/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (30.99 KB - PDF)

**First published:**

28/11/2013

**Last updated:**

10/04/2024

[View](/sv/documents/all-authorised-presentations/abilify-maintena-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Abilify Maintena Active substance aripiprazole International non-proprietary name (INN) or common name aripiprazole Therapeutic area (MeSH) Schizophrenia Anatomical therapeutic chemical (ATC) code N05AX12

### Pharmacotherapeutic group

Psycholeptics

### Therapeutic indication

Maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.

## Authorisation details

EMA product number EMEA/H/C/002755 Marketing authorisation holder

Otsuka Pharmaceutical Netherlands B.V.

Herikerbergweg 292

Opinion adopted 18/09/2013 Marketing authorisation issued 14/11/2013 Revision 24

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Abilify Maintena : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (146.86 KB - PDF)

**First published:** 28/10/2025

[View](/en/documents/procedural-steps-after/abilify-maintena-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Abilify Maintena : EPAR - Procedural steps taken and scientific information after authorisation (archive)

English (EN) (163.72 KB - PDF)

**First published:** 08/04/2014

**Last updated:** 28/10/2025

[View](/en/documents/procedural-steps-after/abilify-maintena-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf)

Abilify Maintena-H-C-PSUSA-00000234-201907 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation

Reference Number: EMA/261452/2020

English (EN) (139.71 KB - PDF)

**First published:** 14/05/2020

[View](/en/documents/scientific-conclusion/abilify-maintena-h-c-psusa-00000234-201907-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisation_en.pdf)

Abilify Maintena-H-C-PSUSA-00000234-201507 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)

Reference Number: EMA/270332/2016

English (EN) (80.58 KB - PDF)

**First published:** 25/05/2016

**Last updated:** 25/05/2016

[View](/en/documents/scientific-conclusion/abilify-maintena-h-c-psusa-00000234-201507-epar-scientific-conclusions-and-grounds-variation-terms-marketing-authorisations_en.pdf)

Abilify Maintena-H-C-PSUSA-0234-201407 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/CHMP/305106/2015

English (EN) (64.53 KB - PDF)

**First published:** 02/06/2015

**Last updated:** 02/06/2015

[View](/en/documents/scientific-conclusion/abilify-maintena-h-c-psusa-0234-201407-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

## Initial marketing authorisation documents

Abilify Maintena : EPAR - Public assessment report

Adopted

Reference Number: EMA/737723/2013

English (EN) (2.96 MB - PDF)

**First published:** 28/11/2013

**Last updated:** 28/11/2013

[View](/en/documents/assessment-report/abilify-maintena-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Abilify Maintena

Adopted

Reference Number: EMA/489804/2013

English (EN) (63.19 KB - PDF)

**First published:** 20/09/2013

**Last updated:** 20/09/2013

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-abilify-maintena_en.pdf)

#### News on Abilify Maintena

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2013](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-16-19-september-2013) 20/09/2013

#### Product information - with tracked changes

The approved product information for this medicine is available below showing the changes since the previous procedure affecting the product information. The same document without tracked changes is above under 'Product information'.

Abilify Maintena : EPAR - Product information - tracked changes

English (EN) (1.3 MB - DOCX)

**First published:** 28/10/2025

[View](/en/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_en.docx)

[Other languages (24)](#file-language-dropdown-620)

български (BG) (1.21 MB - DOCX)

**First published:**

28/10/2025

**Last updated:**

18/12/2025

[View](/bg/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_bg.docx)

español (ES) (1.2 MB - DOCX)

**First published:**

28/10/2025

[View](/es/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_es.docx)

čeština (CS) (6.18 MB - DOCX)

**First published:**

28/10/2025

[View](/cs/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_cs.docx)

dansk (DA) (1.18 MB - DOCX)

**First published:**

28/10/2025

[View](/da/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_da.docx)

Deutsch (DE) (1.19 MB - DOCX)

**First published:**

28/10/2025

[View](/de/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_de.docx)

eesti keel (ET) (1.21 MB - DOCX)

**First published:**

28/10/2025

[View](/et/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_et.docx)

ελληνικά (EL) (1.25 MB - DOCX)

**First published:**

28/10/2025

[View](/el/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_el.docx)

français (FR) (1.2 MB - DOCX)

**First published:**

28/10/2025

[View](/fr/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_fr.docx)

hrvatski (HR) (1.2 MB - DOCX)

**First published:**

28/10/2025

[View](/hr/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_hr.docx)

íslenska (IS) (1.18 MB - DOCX)

**First published:**

28/10/2025

[View](/is/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_is.docx)

italiano (IT) (1.2 MB - DOCX)

**First published:**

28/10/2025

[View](/it/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_it.docx)

latviešu valoda (LV) (1.21 MB - DOCX)

**First published:**

28/10/2025

[View](/lv/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_lv.docx)

lietuvių kalba (LT) (1.19 MB - DOCX)

**First published:**

28/10/2025

[View](/lt/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_lt.docx)

magyar (HU) (1.21 MB - DOCX)

**First published:**

28/10/2025

[View](/hu/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_hu.docx)

Malti (MT) (1.19 MB - DOCX)

**First published:**

28/10/2025

[View](/mt/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_mt.docx)

Nederlands (NL) (1.2 MB - DOCX)

**First published:**

28/10/2025

[View](/nl/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_nl.docx)

norsk (NO) (1.18 MB - DOCX)

**First published:**

28/10/2025

[View](/no/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_no.docx)

polski (PL) (1.22 MB - DOCX)

**First published:**

28/10/2025

[View](/pl/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_pl.docx)

português (PT) (1.2 MB - DOCX)

**First published:**

28/10/2025

[View](/pt/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_pt.docx)

română (RO) (1.21 MB - DOCX)

**First published:**

28/10/2025

[View](/ro/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_ro.docx)

slovenčina (SK) (1.22 MB - DOCX)

**First published:**

28/10/2025

[View](/sk/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_sk.docx)

slovenščina (SL) (1.2 MB - DOCX)

**First published:**

28/10/2025

[View](/sl/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_sl.docx)

Suomi (FI) (1.19 MB - DOCX)

**First published:**

28/10/2025

[View](/fi/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_fi.docx)

svenska (SV) (1.18 MB - DOCX)

**First published:**

28/10/2025

[View](/sv/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_sv.docx)

#### Topics

- [Medicines](https://www.ema.europa.eu/en/search?f%5B0%5D=ema_search_topics%3A61)

**This page was last updated on** 28/10/2025

## Share this page

[Back to top](#main-content)